A team of researchers from the Translational Oncology Research Centre (TORC) of Vrije Universiteit Brussel (VUB), in ...

Regulation of osteoclastogenesis by factors from osteoblasts/stromal cells interacting with receptors on hematopoietic osteoclast precursor cells. RANK-L: receptor activator of NF-kappaB ligand ...

A team of researchers has developed a new biomaterial with high potential in in the treatment of bone lesions or minimal residual disease in multiple myeloma patients. The findings showcase a ...

Discovery of Type R capillaries: key player in bone remodeling, ageing, osteoporosis treatment and bone regeneration.

The team tackled a critical challenge in treating multiple myeloma-a blood cancer where malignant plasma cells accumulate in bone marrow, leading to debilitating bone lesions in 80% of patients.

Bone tissue is composed of cells, namely osteoblasts, osteoclasts and osteocytes, and an extracellular matrix comprising inorganic hydroxyapatite crystals and organic collagen.

impairs bone homeostasis by inhibiting osteoblast differentiation and enhancing adipocyte differentiation via p38γ activation and AMPK suppression. Metformin counters these effects.

The purpose of this review is to describe the available evidence for osteoporosis treatments in young and premenopausal women. A review of articles evaluating the treatment or prevention of ...

Nov. 5, 2024 — Researchers employed analysis tools and machine learning algorithms to identify two genes linked to rheumatoid arthritis and osteoporosis that could serve as diagnostic tools and ...